Drugs / Pizotifen
Pizotifen
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06158230 | Mar → Nov 2023 | migraine disorder | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06500624 | Jun → Aug 2024 | depressive disorder | Riphah International University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pizotifen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06500624 ↗ |
| Known as | Pizotifene | ChEMBL registry synonym — accepted as the source's own label CHEMBL294951 ↗ |
| Known as | Pizotifeno | ChEMBL registry synonym — accepted as the source's own label CHEMBL294951 ↗ |
| Modality | Small molecule | — CHEMBL294951 ↗ |